FDA approves bipolar depression drug

12/30/2003 | Yahoo!

The FDA yesterday gave its approval to Eli Lilly's Symbyax, a drug used to treat the depressive phase of bipolar disorder. Symbyax combines the active ingredients of Prozac and Zyprexa, two other drugs used separately for treating the manic stages of bipolar disorder, but without triggering the manic phase.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD